IBDEI28F ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37490,2)
 ;;=^5055397
 ;;^UTILITY(U,$J,358.3,37491,0)
 ;;=M79.1^^172^1885^33
 ;;^UTILITY(U,$J,358.3,37491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37491,1,3,0)
 ;;=3^Myalgia
 ;;^UTILITY(U,$J,358.3,37491,1,4,0)
 ;;=4^M79.1
 ;;^UTILITY(U,$J,358.3,37491,2)
 ;;=^5013321
 ;;^UTILITY(U,$J,358.3,37492,0)
 ;;=M93.272^^172^1885^36
 ;;^UTILITY(U,$J,358.3,37492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37492,1,3,0)
 ;;=3^Osteochondritis dissecans, l ankle and joints of left foot
 ;;^UTILITY(U,$J,358.3,37492,1,4,0)
 ;;=4^M93.272
 ;;^UTILITY(U,$J,358.3,37492,2)
 ;;=^5015275
 ;;^UTILITY(U,$J,358.3,37493,0)
 ;;=M93.271^^172^1885^42
 ;;^UTILITY(U,$J,358.3,37493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37493,1,3,0)
 ;;=3^Osteochondritis dissecans, right ankle & joints of right foot
 ;;^UTILITY(U,$J,358.3,37493,1,4,0)
 ;;=4^M93.271
 ;;^UTILITY(U,$J,358.3,37493,2)
 ;;=^5015274
 ;;^UTILITY(U,$J,358.3,37494,0)
 ;;=C79.51^^172^1885^52
 ;;^UTILITY(U,$J,358.3,37494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37494,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,37494,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,37494,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,37495,0)
 ;;=L40.51^^172^1885^2
 ;;^UTILITY(U,$J,358.3,37495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37495,1,3,0)
 ;;=3^Arthropathic psoriasis, distal interphalangeal
 ;;^UTILITY(U,$J,358.3,37495,1,4,0)
 ;;=4^L40.51
 ;;^UTILITY(U,$J,358.3,37495,2)
 ;;=^5009166
 ;;^UTILITY(U,$J,358.3,37496,0)
 ;;=L40.52^^172^1885^48
 ;;^UTILITY(U,$J,358.3,37496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37496,1,3,0)
 ;;=3^Psoriatic arthritis mutilans
 ;;^UTILITY(U,$J,358.3,37496,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,37496,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,37497,0)
 ;;=L40.53^^172^1885^51
 ;;^UTILITY(U,$J,358.3,37497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37497,1,3,0)
 ;;=3^Psoriatic spondylitis
 ;;^UTILITY(U,$J,358.3,37497,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,37497,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,37498,0)
 ;;=L40.54^^172^1885^50
 ;;^UTILITY(U,$J,358.3,37498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37498,1,3,0)
 ;;=3^Psoriatic juvenile arthropathy
 ;;^UTILITY(U,$J,358.3,37498,1,4,0)
 ;;=4^L40.54
 ;;^UTILITY(U,$J,358.3,37498,2)
 ;;=^5009169
 ;;^UTILITY(U,$J,358.3,37499,0)
 ;;=L40.59^^172^1885^49
 ;;^UTILITY(U,$J,358.3,37499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37499,1,3,0)
 ;;=3^Psoriatic arthropathy, other
 ;;^UTILITY(U,$J,358.3,37499,1,4,0)
 ;;=4^L40.59
 ;;^UTILITY(U,$J,358.3,37499,2)
 ;;=^5009170
 ;;^UTILITY(U,$J,358.3,37500,0)
 ;;=T79.A11A^^172^1885^12
 ;;^UTILITY(U,$J,358.3,37500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37500,1,3,0)
 ;;=3^Compartment syndrome of right upper extrem, init encntr
 ;;^UTILITY(U,$J,358.3,37500,1,4,0)
 ;;=4^T79.A11A
 ;;^UTILITY(U,$J,358.3,37500,2)
 ;;=^5054326
 ;;^UTILITY(U,$J,358.3,37501,0)
 ;;=T79.A11D^^172^1885^13
 ;;^UTILITY(U,$J,358.3,37501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37501,1,3,0)
 ;;=3^Compartment syndrome of right upper extrem, subs
 ;;^UTILITY(U,$J,358.3,37501,1,4,0)
 ;;=4^T79.A11D
 ;;^UTILITY(U,$J,358.3,37501,2)
 ;;=^5054327
 ;;^UTILITY(U,$J,358.3,37502,0)
 ;;=T79.A12A^^172^1885^6
 ;;^UTILITY(U,$J,358.3,37502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37502,1,3,0)
 ;;=3^Compartment syndrome of left upper extremity, init
 ;;^UTILITY(U,$J,358.3,37502,1,4,0)
 ;;=4^T79.A12A
 ;;^UTILITY(U,$J,358.3,37502,2)
 ;;=^5054329
 ;;^UTILITY(U,$J,358.3,37503,0)
 ;;=T79.A12D^^172^1885^7
 ;;^UTILITY(U,$J,358.3,37503,1,0)
 ;;=^358.31IA^4^2
